NY-HOTWIRE
2.2.2021 16:05:12 CET | Business Wire | Press release
Hotwire, the global technology communications consultancy, today announced it will commit up to $1 million in services to support tech and tech-enabled organizations led by or supporting minority communities. The Program is part of Hotwire’s Diversity, Equity, and Inclusion (DEI) strategy to amplify people and organizations creating meaningful and sustainable change in the world through technology innovation.
“We started the Hotwire Ignite Possibility Program to direct more of our resources to organizations that align with our diversity, equity, and inclusion goals,” said Barbara Bates, CEO. “We have been providing pro bono services to impactful organizations for years, but now, with the Hotwire Ignite Possibility Program, we can do more to advance social justice through our services.”
Any tech or tech-enabled organization—for-profit, non-profit, education, or government—that is either minority-led or providing a product or service benefitting minority communities in a country with a Hotwire office may qualify. Hotwire will work with local community tech leaders addressing inequalities in business and tech to reach organizations who can benefit from brand, marketing or PR pro bono services.
“Having recently had the honor of being named Global Technology Agency of the Year by PRovoke Media, we have a responsibility to lead by example and address the inequality of resources for tech organizations,” noted Bates. “The Hotwire Ignite Possibility Program is one way we can do that,” she added.
Hotwire’s DEI strategy launched in early 2020 and includes specific commitments and a phased rollout schedule. Starting with internal operations and employee engagement initiatives aimed at building a diverse employee population and creating an inclusive environment where differences are celebrated, the firm is now extending the focus externally with the Hotwire Ignite Possibility Program. Hotwire has also signed the Diversity Action Alliance commitment, joining other PR and communications leaders to accelerate progress in the achievement of meaningful and tangible results in diversity, equity and inclusion across our profession.
By earmarking up to $1 million in services to organizations that meet the selection criteria, Hotwire is increasing the amount of support they provide to tech organizations in need of brand, marketing, and public relations expertise that otherwise may not have had access to these resources. The end goal of the Program is to help more tech and tech-enabled organizations that are advancing diversity, equity, and inclusion through technology innovation scale and succeed in today’s competitive tech sector.
Applications are now open for organizations in the US , UK and Germany until March 15th , 2021. An announcement of selected organizations in those countries will be made in April 2021. Applications for Australia open later in 2021 and Hotwire may reopen applications in other regions throughout the year. Follow us on Twitter and LinkedIn to get updates. Have questions? Email HIPP@hotwireglobal.com
About Hotwire
Hotwire is the global technology communications consultancy. Founded in 2000, we operate a worldwide network of wholly owned offices and partners serving a range of clients from scale ups to established multi-nationals. We unleash the possibilities of innovative technology through integrated communications that ignite curiosity, spark action and fuel success. We do this using our proprietary methodology which is underpinned by robust insight and strategy, purposeful creative, integrated planning and a core emphasis on measurement and evaluation.
About Enero
The Enero Group limited, a boutique network of marketing and communication businesses, is listed on the Australian Securities Exchange (asx:EGG). The group includes advertising agency BMF, PR agencies CPR, Frank and Hotwire, digital agency Orchard, research consultancies The Leading Edge and The Digital Edge, and programmatic marketing specialist OB media. For more information, please visit www.enero.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005795/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom